"Light the Night for Amyloidosis" is an awareness campaign designed to raise awareness about the symptoms, diagnosis, treatment, and potential cure for amyloidosis. In honor of 'Amyloidosis Awareness Month' in March, we're encouraging everyone to light up their porch or entryway with red bulbs throughout the month. You can purchase the bulbs in our shop HERE.
Nov 25, 2024
− Prescription Drug User Fee Act (PDUFA) Date Set for March 23, 2025 −
11.22.2024 at 7:12 PM EST
- Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR. Attruby has been shown to preserve the native function of TTR as a transport protein of thyroxine and vitamin A and to demonstrate benefit on cardiovascular outcomes
- Attruby demonstrated the most rapid benefit seen in any Phase 3 study of ATTR-CM to date:
